4547 — Kissei Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- ¥189bn
- ¥129bn
- ¥88bn
- 67
- 42
- 84
- 75
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.07 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -8.4% | ||
| Dividend Yield (f) | 2.73% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.89 | ||
| Price to Tang. Book | 0.9 | ||
| Price to Free Cashflow | 33.5 | ||
| Price to Sales | 2.06 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.21% | ||
| Return on Equity | 6.73% | ||
| Operating Margin | -5.49% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 69,044 | 65,381 | 67,493 | 75,579 | 88,330 | 92,232 | 93,632 | 6.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +44.72 | +178.71 | -21.57 | +6.11 | +39.35 | -11.72 | -6.34 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.
Directors
- Mutsuo Kanzawa CHM (71)
- Yoshio Furihata PRE (59)
- Hiroe Sato VPR (69)
- Keiji Fukushima SMD (65)
- Tetsu Takayama MDR (59)
- Yasuo Takehana MDR (60)
- Suminori Sagara DSL (62)
- Takahide Kitahara OTH (59)
- Shinji Kikuchi OTH (60)
- Eiichi Matsushita OTH (63)
- Masaki Morozumi DRC (66)
- Minoru Nomura IND (74)
- Shigetaka Shimizu IND (72)
- Sayuri Uchikawa IND (70)
- Last Annual
- March 31st, 2025
- Last Interim
- September 30th, 2025
- Incorporated
- August 9th, 1946
- Public Since
- December 22nd, 1988
- No. of Shareholders
- 3,366
- No. of Employees
- 1,778
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 41,452,593
- Address
- 19-48, Yoshino, MATSUMOTO-SHI, 399-8710
- Web
- https://www.kissei.co.jp/
- Phone
- +81 263259081
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4547
Dividend For 4547.T - 60.0000 JPY
Full Year 2026 Kissei Pharmaceutical Co Ltd Earnings Release
Similar to 4547
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Kissei Pharmaceutical Co share price?
As of Today at 20:38 UTC, shares in Kissei Pharmaceutical Co are trading at ¥4,550. This share price information is delayed by 15 minutes.
How has the Kissei Pharmaceutical Co share price performed this year?
Shares in Kissei Pharmaceutical Co last closed at ¥4,550 and the price had moved by +23.31% over the past 365 days. In terms of relative price strength the Kissei Pharmaceutical Co share price has underperformed the Nikkei 225 Index by -3.57% over the past year.
What are the analyst and broker recommendations for Kissei Pharmaceutical Co?
The overall consensus recommendation for Kissei Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kissei Pharmaceutical Co dividend yield?
The Kissei Pharmaceutical Co dividend yield is 2.53% based on the trailing twelve month period.
Does Kissei Pharmaceutical Co pay a dividend?
Last year, Kissei Pharmaceutical Co paid a total dividend of ¥115, and it currently has a trailing dividend yield of 2.53%.Looking ahead, shares in Kissei Pharmaceutical Co are due to go ex-dividend on 2026-03-30 and the next dividend pay date is 2025-12-03.
When does Kissei Pharmaceutical Co next pay dividends?
Kissei Pharmaceutical Co are due to go ex-dividend on 2026-03-30 and the next dividend pay date is 2025-12-03. The historic dividend yield on Kissei Pharmaceutical Co shares is currently 2.53%.
How do I buy Kissei Pharmaceutical Co shares?
To buy shares in Kissei Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kissei Pharmaceutical Co?
As of the previous close price of ¥4,550, shares in Kissei Pharmaceutical Co had a market capitalisation of ¥189bn.
Where are Kissei Pharmaceutical Co shares listed?
Here are the trading details for Kissei Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4547
What kind of share is Kissei Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Kissei Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kissei Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in Kissei Pharmaceutical Co is ¥4,820. That is 5.93% above the last closing price of ¥4,550.
Analysts covering Kissei Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of ¥295 for the next financial year.
Find out moreWhat is the trend in the Kissei Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kissei Pharmaceutical Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -8.9%.
As of the last closing price of ¥4,550, shares in Kissei Pharmaceutical Co were trading +12.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kissei Pharmaceutical Co PE Ratio?
The Kissei Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 16.07. The shares last closed at ¥4,550.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kissei Pharmaceutical Co?
Kissei Pharmaceutical Co's management team is headed by:
- Mutsuo Kanzawa - CHM
- Yoshio Furihata - PRE
- Hiroe Sato - VPR
- Keiji Fukushima - SMD
- Tetsu Takayama - MDR
- Yasuo Takehana - MDR
- Suminori Sagara - DSL
- Takahide Kitahara - OTH
- Shinji Kikuchi - OTH
- Eiichi Matsushita - OTH
- Masaki Morozumi - DRC
- Minoru Nomura - IND
- Shigetaka Shimizu - IND
- Sayuri Uchikawa - IND